glp-1 colorectal cancer death risk study november 2025 GLP-1s in Oncology: Exploring Risks and Potential Benefits Ozempic, Wegovy might lower colon GLP-1 receptor agonists show anti-cancer

These FDA-approved dosing schedules represent standard protocols, though individual patient circumstances may necessitate modifications under physician guidance

This could be a big deal for companies that are selling protein shakes but not marketing directly for weight loss, products like Fairlife or Premier Protein ready-to-drink shakes could see big volume increases potentially as market penetration increases and insurance coverage becomes more broad

De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrm E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis

Why do I feel tired on GLP-1 medication

While prior gallbladder disease is not an absolute contraindication, it may influence the risk-benefit assessment